Sunday - October 26, 2025
Oral GLP-1 drug promotes substantial weight loss in trial
September 23, 2025
ITHACA, New York, Sept. 23 -- Cornell University posted the following news:

* * *

Oral GLP-1 drug promotes substantial weight loss in trial

*

Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.

The results fr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products